Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II intravenous azithromycin for gastric MALT lymphoma
2020-003152-33Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of azithromycin in Gastric Marginal Zone B-Cell Lymphoma Of Mucosa-Associated Lymphoid Tissue, sponsored by Medical University of Vienna. Primary endpoint: Objective response rate. Started Jul 2020; status: completed.
02
Drugs
azithromycin
03
Conditions
Gastric Marginal Zone B-Cell Lymphoma Of Mucosa-Associated Lymphoid Tissue
Beyond the preview
Go deeper on 2020-003152-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003152-33.